The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $2.56

Today's change+0.13 +5.35%
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $2.56

Today's change+0.13 +5.35%
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.

ImmunoGen Inc up sharply

ImmunoGen Inc closed up sharply Tuesday, rallying (U.S.)$0.13 or 5.35% to (U.S.)$2.56. Over the last five days, shares have gained 1.99%, but are down 73.08% for the last 52 weeks, lagging the 20.61% return in the S&P 500.

Key company metrics

  • Open(U.S.) $2.40
  • Previous close(U.S.) $2.43
  • High(U.S.) $2.61
  • Low(U.S.) $2.30
  • Bid / Ask(U.S.) $2.61 / (U.S.) $2.68
  • YTD % change+25.49%
  • Volume3,494,893
  • Average volume (10-day)4,628,855
  • Average volume (1-month)2,635,074
  • Average volume (3-month)1,780,571
  • 52-week range(U.S.) $1.51 to (U.S.) $10.22
  • Beta1.98
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.79
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.25%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue872018
Total other revenue--------
Total revenue872018
Gross profit--------
Total cost of revenue--------
Total operating expense46484746
Selling / general / administrative99118
Research & development33393638
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4------
Other operating expenses, total--------
Operating income-39-41-28-28
Interest income (expense), net non-operating-1------
Gain (loss) on sale of assets--------
Other--------
Income before tax-45-46-32-33
Income after tax-45-46-32-33
Income tax, total--------
Net income-45-46-32-33
Total adjustments to net income--------
Net income before extra. items-45-46-32-33
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-45-46-32-33
Inc. avail. to common incl. extra. items-45-46-32-33
Diluted net income-45-46-32-33
Dilution adjustment--------
Diluted weighted average shares87878787
Diluted EPS excluding extraordinary itemsvalue per share-0.51-0.53-0.37-0.38
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.47-0.53-0.37-0.38